256 related articles for article (PubMed ID: 29023184)
1. Disease-associated protein seeding suggests a dissociation between misfolded protein accumulation and neurodegeneration in prion disease.
Alibhai J; Diack A; Manson J
Prion; 2017 Nov; 11(6):381-387. PubMed ID: 29023184
[TBL] [Abstract][Full Text] [Related]
2. Distribution of Misfolded Prion Protein Seeding Activity Alone Does Not Predict Regions of Neurodegeneration.
Alibhai J; Blanco RA; Barria MA; Piccardo P; Caughey B; Perry VH; Freeman TC; Manson JC
PLoS Biol; 2016 Nov; 14(11):e1002579. PubMed ID: 27880767
[TBL] [Abstract][Full Text] [Related]
3. Protein misfolding and neurodegeneration.
Soto C; Estrada LD
Arch Neurol; 2008 Feb; 65(2):184-9. PubMed ID: 18268186
[TBL] [Abstract][Full Text] [Related]
4. Generalization of the prion hypothesis to other neurodegenerative diseases: an imperfect fit.
Guest WC; Silverman JM; Pokrishevsky E; O'Neill MA; Grad LI; Cashman NR
J Toxicol Environ Health A; 2011; 74(22-24):1433-59. PubMed ID: 22043906
[TBL] [Abstract][Full Text] [Related]
5. RNA-seq and network analysis reveal unique glial gene expression signatures during prion infection.
Carroll JA; Race B; Williams K; Striebel J; Chesebro B
Mol Brain; 2020 May; 13(1):71. PubMed ID: 32381108
[TBL] [Abstract][Full Text] [Related]
6. Microglia in Prion Diseases: Angels or Demons?
Peggion C; Stella R; Lorenzon P; Spisni E; Bertoli A; Massimino ML
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33092220
[TBL] [Abstract][Full Text] [Related]
7. The cell biology of prion-like spread of protein aggregates: mechanisms and implication in neurodegeneration.
Costanzo M; Zurzolo C
Biochem J; 2013 May; 452(1):1-17. PubMed ID: 23614720
[TBL] [Abstract][Full Text] [Related]
8. Recombinant Mammalian Prions: The "Correctly" Misfolded Prion Protein Conformers.
Ma J; Zhang J; Yan R
Viruses; 2022 Aug; 14(9):. PubMed ID: 36146746
[TBL] [Abstract][Full Text] [Related]
9. Targeting Neuroinflammation by Pharmacologic Downregulation of Inflammatory Pathways Is Neuroprotective in Protein Misfolding Disorders.
Risen SJ; Boland SW; Sharma S; Weisman GM; Shirley PM; Latham AS; Hay AJD; Gilberto VS; Hines AD; Brindley S; Brown JM; McGrath S; Chatterjee A; Nagpal P; Moreno JA
ACS Chem Neurosci; 2024 Apr; 15(7):1533-1547. PubMed ID: 38507813
[TBL] [Abstract][Full Text] [Related]
10. The role of astrocytes in prion-like mechanisms of neurodegeneration.
Smethurst P; Franklin H; Clarke BE; Sidle K; Patani R
Brain; 2022 Mar; 145(1):17-26. PubMed ID: 35265969
[TBL] [Abstract][Full Text] [Related]
11. Microglia deficiency accelerates prion disease but does not enhance prion accumulation in the brain.
Bradford BM; McGuire LI; Hume DA; Pridans C; Mabbott NA
Glia; 2022 Nov; 70(11):2169-2187. PubMed ID: 35852018
[TBL] [Abstract][Full Text] [Related]
12. Sustained translational repression by eIF2α-P mediates prion neurodegeneration.
Moreno JA; Radford H; Peretti D; Steinert JR; Verity N; Martin MG; Halliday M; Morgan J; Dinsdale D; Ortori CA; Barrett DA; Tsaytler P; Bertolotti A; Willis AE; Bushell M; Mallucci GR
Nature; 2012 May; 485(7399):507-11. PubMed ID: 22622579
[TBL] [Abstract][Full Text] [Related]
13. Prions: generation and spread versus neurotoxicity.
Halliday M; Radford H; Mallucci GR
J Biol Chem; 2014 Jul; 289(29):19862-8. PubMed ID: 24860100
[TBL] [Abstract][Full Text] [Related]
14. Effect of Microglial Inflammation in Prion Disease.
Ano Y; Sakudo A; Onodera T
Curr Issues Mol Biol; 2020; 36():1-12. PubMed ID: 31486773
[TBL] [Abstract][Full Text] [Related]
15. Diminished Neuronal ESCRT-0 Function Exacerbates AMPA Receptor Derangement and Accelerates Prion-Induced Neurodegeneration.
Lawrence JA; Aguilar-Calvo P; Ojeda-Juárez D; Khuu H; Soldau K; Pizzo DP; Wang J; Malik A; Shay TF; Sullivan EE; Aulston B; Song SM; Callender JA; Sanchez H; Geschwind MD; Roy S; Rissman RA; Trejo J; Tanaka N; Wu C; Chen X; Patrick GN; Sigurdson CJ
J Neurosci; 2023 May; 43(21):3970-3984. PubMed ID: 37019623
[TBL] [Abstract][Full Text] [Related]
16. Loss of Homeostatic Microglia Signature in Prion Diseases.
Wang Y; Hartmann K; Thies E; Mohammadi B; Altmeppen H; Sepulveda-Falla D; Glatzel M; Krasemann S
Cells; 2022 Sep; 11(19):. PubMed ID: 36230910
[TBL] [Abstract][Full Text] [Related]
17. Molecular cross talk between misfolded proteins in animal models of Alzheimer's and prion diseases.
Morales R; Estrada LD; Diaz-Espinoza R; Morales-Scheihing D; Jara MC; Castilla J; Soto C
J Neurosci; 2010 Mar; 30(13):4528-35. PubMed ID: 20357103
[TBL] [Abstract][Full Text] [Related]
18. Prion Diseases: A Unique Transmissible Agent or a Model for Neurodegenerative Diseases?
Ritchie DL; Barria MA
Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33540845
[TBL] [Abstract][Full Text] [Related]
19. The Role of Glial Cells in Neurobiology and Prion Neuropathology.
Hay A; Popichak K; Moreno J; Zabel M
Cells; 2024 May; 13(10):. PubMed ID: 38786054
[TBL] [Abstract][Full Text] [Related]
20. Neuronal death induced by misfolded prion protein is due to NAD+ depletion and can be relieved in vitro and in vivo by NAD+ replenishment.
Zhou M; Ottenberg G; Sferrazza GF; Hubbs C; Fallahi M; Rumbaugh G; Brantley AF; Lasmézas CI
Brain; 2015 Apr; 138(Pt 4):992-1008. PubMed ID: 25678560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
